Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Americans’ choices, often informed by bad or misleading data, are among the causes of poor health.
People who used cholesterol-lowering medications had a 40% lower risk for liver disease progression.
Use of cholesterol-lowering medications was also associated with reduced mortality from liver cancer and other causes.
Overall survival increased by 30% among women with aggressive breast cancer who began statin use post-diagnosis.
Cholesterol-lowering meds may reduce cardiotoxic chemotherapy side effects in women with early breast cancer.
Taking a combination of statins, metformin and aspirin may mean less lung cancer.
Cholesterol-lowering medications were associated with at least a 40% reduction in mortality.
Anthracycline chemotherapy and the targeted therapy trastuzumab can harm women’s hearts.
Combining the cholesterol-lowering drugs with the diabetes drug metformin may be even better.
That’s the core message of an essay by Anthony S. Fauci, MD, director of the National Institute of Allergy and Infectious Diseases.
Researchers think that statins’ anti-inflammatory effects may be responsible for this association.
This held true regardless of whether statins were taken before or after the cancer diagnosis.
Highlights from HIV and hepatitis C research presented at the 2018 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston
Statin users were less likely to develop several types of cancer in a large study.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.